vidprevtyn beta
sanofi pasteur - sars-cov-2 prefusion spike delta tm protein, recombinant (b.1.351 strain) - covid-19 virus infection - Ваксини - vidprevtyn beta is indicated as a booster for active immunisation to prevent covid-19 in adults who have previously received an mrna or adenoviral vector covid-19 vaccine (see sections 4. 2 и 5. 1 in product information document). Използването на тази ваксина трябва да бъде приложена в съответствие с официалните препоръки.
betaklav 500 mg/125 mg film - coated tablets
krka, d.d. novo mesto - Амоксицилин и инхибитор на ензима - 500 mg/125 mg film - coated tablets
betaklav 875 mg/125 mg film - coated tablets
krka, d.d. novo mesto - Амоксицилин и инхибитор на ензима - 875 mg/125 mg film - coated tablets
betaklav 400 mg/57 mg/5 ml powder for oral suspension
krka, d.d. novo mesto - Амоксицилин и инхибитор на ензима - 400 mg/57 mg/5 ml powder for oral suspension
betaderm a 0,5 mg/g + 30 mg/g ointment
pharmaswiss ceska republika s.r.o. - 0,5 mg/g + 30 mg/g ointment
betaloc zok 50 mg prolonged - release tablets
astra zeneca ab - Метопролол - 50 mg prolonged - release tablets
betaloc zok 100 mg prolonged - release tablets
astra zeneca ab - Метопролол - 100 mg prolonged - release tablets
betadine 200 mg pessaries
egis pharmaceuticals public limited company - Повидон-йод - 200 mg pessaries
cevenfacta
laboratoire francais du fractionnement et des biotechnologies - eptacog beta (activated) - hemophilia a; hemophilia b - Антихеморагични - cevenfacta is indicated in adults and adolescents (12 years of age and older) for the treatment of bleeding episodes and for the prevention of bleeding in those undergoing surgery or invasive procedures in the following patient groups:in patients with congenital haemophilia with high-responding inhibitors to coagulation factors viii or ix (i. ≥5 bethesda units (bu)); in patients with congenital haemophilia with low titre inhibitors (bu.
meta - idobenyluanidine for diagnostik use 9,25 - 18,5 mbq/ml solution for injection
ge healthcare buchler gmbh & co. kg - Натриев йодид [131i по] - 9,25 - 18,5 mbq/ml solution for injection